Abstract
Antitumor effects of combined transfer of P16 and cytokine genes were investigated in this study. The adenovirus harboring the P16 gene (AdP16) and murine granulocyte–macrophage colony-stimulating factor gene (AdGM-CSF) were utilized for the treatment of established tumors. The mice were inoculated subcutaneously with Renca cells and, 6 days later, received an intratumoral injection of AdP16 in the presence or absence of AdGM-CSF. The results demonstrated that tumor-bearing mice treated with AdP16 in combination with AdGM-CSF showed more potent inhibition of tumor growth and survived much longer than did mice treated with AdP16, AdGM-CSF, adenovirus expressing β-galactosidase, or phosphate-buffered saline alone (P<.01). The tumor mass showed obvious necrosis and inflammatory cell infiltration, and more CD4+ and CD8+ T cells infiltrating the tumor after combined therapy. After combined therapy, the expression of MHC-1 (H-2Kd) and Fas molecules on freshly isolated tumor cells increased greatly. The activity of specific cytotoxic T lymphocytes was also found to be induced more significantly after the combined therapy (P<.01). Our results demonstrated that combined therapy with P16 and GM-CSF genes can inhibit the growth of established tumors in mice significantly and induce antitumor immunity of the host efficiently.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Serrano M, Gregory J, Beach HD . A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 Nature 1993 366: 704–707
Volker S, Karsten B, Susanne H et al. Adenovirally transferred P16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death Nat Med 1997 3: 313–319
Kamb A, Gruis NA, Weaver-feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumor types Science 1994 264: 436–440
Kinoshita H, Yanada H, Ogawa O et al. Contribution of chromosome 9p21–22 deletion to the progression of human renal cell carcinoma Jpn J Cancer Res 1995 86: 795–799
Figlin RA, Gitlitz BJ, Belldegrun A . Immunologic approaches to the treatment of cancer Cancer Invest 1995 13: 339–340 (Editorial)
Ju DW, Cao X, Acres B et al. Intratumoral injection of GM-CSF gene-encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model Cancer Gene Ther 1997 4: 139–144
Ju DW, Wang BM, Cao X et al. Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity J Cancer Res Clin Oncol 1998 124: 683–689
Cao X, Ju DW, Tao Q et al. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor bearing mice Gene Ther 1998 5: 1130–1136
Cao X, Wang Q, Ju DW et al. Efficient induction of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene J Exp Clin Cancer Res 1999 18: 191–200
Wang LH, Ju DW, Sun YH et al. The potent antitumor effects of combined p16 gene and GM-CSF gene therapy through efficient induction of antitumor immunity J Cancer Res Clin Oncol 2001 127: 101–108
Qin H, Chatterjee SK . Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF Hum Gene Ther 1996 8: 1853–1860
Mahvi DM, Sondel PM, Yang NS et al. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma Hum Gene Ther 1997 8: 875–891
Shi FS, Weber S, Gan J et al. Granulocyte–macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF Cancer Gene Ther 1999 6: 81–88
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, L., Qi, X., Sun, Y. et al. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity. Cancer Gene Ther 9, 819–824 (2002). https://doi.org/10.1038/sj.cgt.7700502
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700502
Keywords
This article is cited by
-
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
npj Precision Oncology (2021)
-
Granulocyte–macrophage colony-stimulating factor: not just another haematopoietic growth factor
Medical Oncology (2014)
-
Cancer gene therapy: an awkward adolescence
Cancer Gene Therapy (2003)